Huang P - Search Results

1

Development and validation of an endoscopic images-based deep learning model for detection with nasopharyngeal malignancies.

Li C, Jing B, Ke L, Li B, Xia W, He C, Qian C, Zhao C, Mai H, Chen M, Cao K, Mo H, Guo L, Chen Q, Tang L, Qiu W, Yu Y, Liang H, Huang X, Liu G, Li W, Wang L, Sun R, Zou X, Guo S, Huang P, Luo D, Qiu F, Wu Y, Hua Y, Liu K, Lv S, Miao J, Xiang Y, Sun Y, Guo X, Lv X. Li C, et al. Among authors: huang p, huang x. Cancer Commun (Lond). 2018 Sep 25;38(1):59. doi: 10.1186/s40880-018-0325-9. Cancer Commun (Lond). 2018. PMID: 30253801 Free PMC article.

2

Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma.

Zhang J, Fang W, Qin T, Yang Y, Hong S, Liang W, Ma Y, Zhao H, Huang Y, Xue C, Huang P, Hu Z, Zhao Y, Zhang L. Zhang J, et al. Among authors: huang p, huang y. Med Oncol. 2015 Mar;32(3):86. doi: 10.1007/s12032-015-0501-6. Epub 2015 Feb 22. Med Oncol. 2015. PMID: 25702326

3

Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinoma.

Hou X, Wu X, Huang P, Zhan J, Zhou T, Ma Y, Qin T, Luo R, Feng Y, Xu Y, Chen L, Zhang L. Hou X, et al. Among authors: huang p. Int J Cancer. 2015 Oct 1;137(7):1672-8. doi: 10.1002/ijc.29540. Epub 2015 Apr 29. Int J Cancer. 2015. PMID: 25824984

4

Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing.

Hu L, Lin Z, Wu Y, Dong J, Zhao B, Cheng Y, Huang P, Xu L, Xia T, Xiong D, Wang H, Li M, Guo L, Kieff E, Zeng Y, Zhong Q, Zeng M. Hu L, et al. Among authors: huang p. Front Med. 2016 Mar;10(1):61-75. doi: 10.1007/s11684-016-0436-0. Epub 2016 Mar 11. Front Med. 2016. PMID: 26969667

5

Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment.

Liang W, Shen G, Zhang Y, Chen G, Wu X, Li Y, Li A, Kang S, Yuan X, Hou X, Huang P, Huang Y, Zhao H, Tian Y, Zhao C, Zhang L. Liang W, et al. Among authors: huang p, huang y. Chin J Cancer. 2016 Nov 25;35(1):98. doi: 10.1186/s40880-016-0160-9. Chin J Cancer. 2016. PMID: 27887636 Free PMC article.

6

Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: an open-label single-arm, phase II trial.

Hua Y, You R, Wang Z, Huang P, Lin M, Ouyang Y, Xie Y, Zou X, Liu Y, Duan C, Liu Y, Gu C, Liu R, Yang Q, Jiang R, Zhang M, Ding X, Chen S, Lin C, Sun R, Chen M. Hua Y, et al. Among authors: huang p. J Immunother Cancer. 2021 Nov;9(11):e003290. doi: 10.1136/jitc-2021-003290. J Immunother Cancer. 2021. PMID: 34782428 Free PMC article. Clinical Trial.

7

Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients.

Blanchard P, Lee AWM, Carmel A, Wai Tong N, Ma J, Chan ATC, Hong RL, Chen MY, Chen L, Li WF, Huang PY, Kwong DLW, Poh SSX, Ngan R, Mai HQ, Ollivier C, Fountzilas G, Zhang L, Bourhis J, Aupérin A, Lacas B, Pignon JP; MAC-NPC collaborative Group. Blanchard P, et al. Among authors: huang py. Clin Transl Radiat Oncol. 2021 Nov 26;32:59-68. doi: 10.1016/j.ctro.2021.11.007. eCollection 2022 Jan. Clin Transl Radiat Oncol. 2021. PMID: 34935776 Free PMC article.

8

Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis.

Petit C, Lee A, Ma J, Lacas B, Ng WT, Chan ATC, Hong RL, Chen MY, Chen L, Li WF, Huang PY, Tan T, Ngan RKC, Zhu G, Mai HQ, Hui EP, Fountzilas G, Zhang L, Carmel A, Kwong DLW, Moon J, Bourhis J, Auperin A, Pignon JP, Blanchard P; MAC-NPC Collaborative Group. Petit C, et al. Among authors: huang py. Lancet Oncol. 2023 Jun;24(6):611-623. doi: 10.1016/S1470-2045(23)00163-8. Lancet Oncol. 2023. PMID: 37269842

9

Open-label, single-arm phase II study of pemetrexed in the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma who have had prior platinum-based chemotherapy.

Zhang Y, Zhao L, Huang P, Wu J, Wang F, Huang Y, Zhang L. Zhang Y, et al. Among authors: huang p, huang y. Cancer Chemother Pharmacol. 2012 Oct;70(4):611-5. doi: 10.1007/s00280-012-1950-7. Epub 2012 Aug 19. Cancer Chemother Pharmacol. 2012. PMID: 22903536 Clinical Trial.

10

Inhibition of eEF-2 kinase sensitizes human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways.

Liu L, Huang P, Wang Z, Chen N, Tang C, Lin Z, Peng P. Liu L, et al. Among authors: huang p. BMC Cancer. 2016 Oct 19;16(1):813. doi: 10.1186/s12885-016-2853-5. BMC Cancer. 2016. PMID: 27756261 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,863 results

Search Page

Filters